Evogene (EVGN)

Evogene (EVGN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $6.1M; returns 1 day -3.1%, 1 week -5.7%, 1 year -70.6%.

Evogene Ltd. is an Israel-based computational biology company focusing on revolutionizing the development of life-science-based products. Following a strategic shift completed in 2025, Evogene is now specializing in computational chemistry, centered around its ChemPass AI platform.

Groups EVGN belongs to

• Israel Companies
• Israel
• Biotechnology
• Artificial Intelligence
• AI Business Integration
• Life Sciences
• Drug Discovery
• AgTech
• Agribusiness
• Sustainable Agriculture

EVGN financial model: income statement, cash flow and balance sheet